Pro-Apoptotic Activity of the Marine Sponge
5-epi-ilimaquinone
Dactylospongia elegans
apoptosis
marine sponge
melanoma
microRNA
pelorol
Journal
Marine drugs
ISSN: 1660-3397
Titre abrégé: Mar Drugs
Pays: Switzerland
ID NLM: 101213729
Informations de publication
Date de publication:
28 Jun 2022
28 Jun 2022
Historique:
received:
31
05
2022
revised:
24
06
2022
accepted:
24
06
2022
entrez:
25
7
2022
pubmed:
26
7
2022
medline:
28
7
2022
Statut:
epublish
Résumé
The natural environment represents an important source of drugs that originates from the terrestrial and, in minority, marine organisms. Indeed, the marine environment represents a largely untapped source in the process of drug discovery. Among all marine organisms, sponges with algae represent the richest source of compounds showing anticancer activity. In this study, the two secondary metabolites pelorol (PEL) and 5-
Identifiants
pubmed: 35877720
pii: md20070427
doi: 10.3390/md20070427
pmc: PMC9317990
pii:
doi:
Substances chimiques
MIRN214 microRNA, human
0
MicroRNAs
0
Quinones
0
Sesquiterpenes
0
pelorol
0
ilimaquinone
5U0WAN3N8Q
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
J Nat Prod. 2020 Mar 27;83(3):770-803
pubmed: 32162523
Int J Mol Sci. 2018 Dec 08;19(12):
pubmed: 30544835
Nat Rev Drug Discov. 2017 Mar;16(3):203-222
pubmed: 28209991
Nat Rev Clin Oncol. 2017 Aug;14(8):463-482
pubmed: 28374786
Z Naturforsch C J Biosci. 2018 Sep 25;73(9-10):397-400
pubmed: 29813035
EMBO J. 2011 May 18;30(10):1990-2007
pubmed: 21468029
Blood. 2007 Sep 15;110(6):1942-9
pubmed: 17502453
J Nat Prod. 2009 Dec;72(12):2120-4
pubmed: 19921834
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Chimia (Aarau). 2017 Oct 25;71(10):646-652
pubmed: 29070409
Mar Drugs. 2014 May 12;12(5):2771-89
pubmed: 24824024
Cell Death Dis. 2018 Jan 25;9(2):112
pubmed: 29371600
J Nat Prod. 2011 Jan 28;74(1):65-8
pubmed: 21155589
Mar Drugs. 2016 Jun 21;14(6):
pubmed: 27338420
Apoptosis. 2013 Jul;18(7):896-909
pubmed: 23546867
PLoS One. 2012;7(2):e31518
pubmed: 22359598
Cancer Res. 1999 Apr 1;59(7):1391-9
pubmed: 10197600
Org Biomol Chem. 2018 Sep 19;16(36):6773-6782
pubmed: 30191932
Experientia. 1992 Sep 15;48(9):891-2
pubmed: 1397187
PLoS One. 2013;8(2):e55276
pubmed: 23408966
Cancer Cell Int. 2015 Apr 02;15:38
pubmed: 25960691
Cell Biosci. 2021 Jan 07;11(1):8
pubmed: 33413657
Invest New Drugs. 2002 Nov;20(4):407-12
pubmed: 12448658
J Nat Prod. 2000 Aug;63(8):1153-6
pubmed: 10978216
Front Endocrinol (Lausanne). 2018 Aug 03;9:402
pubmed: 30123182
Mar Drugs. 2019 Jan 07;17(1):
pubmed: 30621025
Immunotargets Ther. 2018 Jun 07;7:35-49
pubmed: 29922629
Anticancer Drugs. 2015 Aug;26(7):754-62
pubmed: 25974027
Org Lett. 2005 Mar 17;7(6):1073-6
pubmed: 15760142
Br J Dermatol. 2017 Jul;177(1):134-140
pubmed: 28369739
Angew Chem Int Ed Engl. 2017 Apr 24;56(18):4987-4990
pubmed: 28370791
Clin Cancer Res. 2015 Nov 1;21(21):4903-12
pubmed: 26089374
J Nat Prod. 2000 Aug;63(8):1150-2
pubmed: 10978215
Mar Drugs. 2018 May 16;16(5):
pubmed: 29772645
Int J Mol Sci. 2018 May 25;19(6):
pubmed: 29799486
Eur J Pharmacol. 2007 Feb 5;556(1-3):45-54
pubmed: 17140562
J Cell Sci. 2003 Sep 15;116(Pt 18):3677-85
pubmed: 12917355
Nat Med. 2008 Nov;14(11):1271-7
pubmed: 18931683
Int J Mol Med. 2015 May;35(5):1395-402
pubmed: 25738546
Bioorg Med Chem. 2020 Feb 15;28(4):115279
pubmed: 31980363
J Nat Prod. 1997 Feb;60(2):93-7
pubmed: 9051909
Oncol Rep. 2013 Apr;29(4):1652-8
pubmed: 23380758
J Pharm Pharmacol. 2020 Dec;72(12):1732-1749
pubmed: 32783235
Pathol Oncol Res. 2011 Dec;17(4):931-7
pubmed: 21688200
Life (Basel). 2021 Dec 11;11(12):
pubmed: 34947921
Pharmaceuticals (Basel). 2021 Dec 18;14(12):
pubmed: 34959729
J Biol Chem. 2007 Feb 2;282(5):3173-81
pubmed: 17095507
Int J Mol Sci. 2020 Aug 27;21(17):
pubmed: 32867069
Nat Rev Drug Discov. 2021 Mar;20(3):200-216
pubmed: 33510482